Novartis India Ltd share price logo

Novartis India Ltd

NSE: NOVARTIND

BSE: 500672

Small Cap

Pharma Sector

₹2014.00

-174.00

(-7.95%)

as on

bell
The current prices are delayed by 15 mins, login to check live prices.

Tech Chart

What are INDmoney investors doing with Novartis India shares?

Based on platform-user behaviour - not analyst opinion or company fundamentals.

Search interest on INDmoney

+318%

Searches for Novartis India on INDmoney have increased by 318% over the last 30 days.

Investment activity on INDmoney

+858.70%

Investment activity in Novartis India among INDmoney users has increased by 858.70% over the last 30 days.

Key Events for Novartis India

Last Dividend Declared

₹25.00 per share, declared on 09/05/2025

View Dividend History

Novartis India Stock Performance

as on September 16, 2026 at 7:47 pm IST

  • Day's Low

    Day's High

    ₹1,980.00
    ₹2,178.10
    downward going graph

    1.69%

    Downside

    8.15%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    ₹950.00
    ₹2,588.80
    downward going graph

    52.83%

    Downside

    28.54%

    Upside

    downward going graph

Novartis India share price movements today

Previous Close
₹2,188.00
Open
₹2,014.00
Volume
1.00L
Upper Circuit
₹2,406.80
Lower Circuit
₹1,969.20
Day's Low - High
₹1,980.00 - ₹2,178.10
52 Week Low - High
₹950.00 - ₹2,588.80

Novartis India Historical Returns

1 Month Return
+ 37.69 %
3 Month Return
+ 65.32 %
1 Year Return
+ 142.61 %
3 Year Return
+ 193.26 %
5 Year Return
+ 161.35 %

Novartis India Fundamentals

as on September 16, 2026 at 2:17 pm IST

Market Cap

₹5,402.35 Cr

Return on Equity (ROE)

11.63

PE Ratio (TTM)

60.37

Return on capital employed (ROCE)

15.94

Industry PE ratio

51.81

Beta (LTM)

-0.78

P/B Ratio

2.93

Dividend Yield

0

PEG Ratio

-29.74

Quarterly Earnings Growth YOY

16.62

EPS (TTM)

0

Book Value

0

Novartis India Stock Valuation

as on September 16, 2026 at 2:17 pm IST

Novartis India in the last 5 years

  • Overview

  • Trends

Lowest (-436.09x)

April 11, 2022

Industry (51.81x)

September 11, 2026

Today (60.37x)

September 11, 2026

Highest (113.24x)

July 14, 2021

LowHigh

Today’s Price to Earnings Ratio: 60.37x

Novartis India Technical Analysis

Track how Novartis India technical analysis has moved over time to understand its trends.

1 min
5 min
15 min
30 min
1 day
1 week
1 month

Technicals Summary

Bearish

Neutral

Bullish

Bearish

Moving Averages

Bearish

Neutral

Bullish

Bearish

Oscillators

Bearish

Neutral

Bullish

Bearish

Overall

Bearish12
Bullish2
Neutral1

Oscillators

Name

Value

Action

MACD level (12,26)
-1.46
Bearish
CCI (20)
550.14
Bearish
RSI (14)
42.18
Neutral
Momentum (10)
-4.1
Bullish
ADI (14)
27.91
Bearish
Ultimate Oscillator (7,14,28)
15.4
Bearish

Moving Averages

Name

Value

Action

SMA (20)
2010.85
Bearish
EMA (20)
2009.28
Bearish
VWMA (20)
2009.53
Bearish
SMA (50)
2011.02
Bearish
EMA (50)
2011.26
Bearish
SMA (200)
2018.47
Bearish
EMA (200)
2027.68
Bearish
KAMA (200)
2016.23
Bearish
DEMA (200)
1991.95
Bullish

Novartis India Ltd vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Novartis India with its industry peers.

Company
Analyst View
Market Cap(in ₹ Cr)
5 Year CAGRDebt to Asset Ratio
Net Profit(in ₹ Cr)
Yearly Revenue(in ₹ Cr)
Novartis India Ltd image
Novartis India Ltd
NA5,402.3532.27%0.0093376
Bacil Pharma Ltd image
Bacil Pharma Ltd
NA29.1947.69%0.001NA
Concord Biotech Ltd image
Concord Biotech Ltd
BUY15,409.9711.25%0.502591,054
Beryl Drugs Ltd image
Beryl Drugs Ltd
NA11.7921.54%0.00-121
Natco Pharma Ltd image
Natco Pharma Ltd
HOLD14,671.79-3.06%0.541,3714,078
See all

Novartis India Ltd Quarterly Profit & Loss

Figures in Rupees Crores

Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Sales
78.76
84.54
81.17
92.29
87.1
93
83.88
87.55
90.33
85.9
90.55
103.81
Other Income
16.88
21.96
10.42
10.41
10.32
10.6
10.63
10.61
9.4
8.75
10.01
8.74
Total Income
95.64
106.5
91.59
102.7
97.42
103.6
94.51
98.16
99.73
94.65
100.56
112.55
Expenses
61.85
64.77
69.96
68.32
69.14
67.42
59.97
60.31
66.45
63.54
69.93
68.9
Operating Profit
16.91
19.77
11.21
23.97
17.96
25.58
23.91
27.24
23.88
22.36
20.62
34.91
Operating Profit Margin %
21.47%
23.39%
13.81%
25.97%
20.62%
27.51%
28.51%
31.11%
26.44%
26.03%
22.77%
33.63%
Profit Before Interest, Tax and Depreciation
33.79
41.73
21.63
34.38
28.28
36.18
34.54
37.85
33.28
31.11
30.63
43.65
Interest
0.71
0.16
0.16
0.15
0.14
0.36
0.12
0.1
0.11
0.98
0.07
0.06
Depreciation
0.65
0.26
0.14
0.55
0.58
0.53
0.53
0.53
0.52
0.48
0.42
0.42
Profit Before Tax
32.43
41.31
21.33
33.68
27.56
35.29
33.89
37.22
32.65
29.65
30.14
43.17
Tax Paid
8.75
14.74
6.65
7.94
7.15
9.84
4.59
9.6
8.43
13.56
4.89
10.96
Profit After Tax
23.68
26.57
14.68
25.74
20.41
25.45
29.3
27.62
24.22
16.09
25.25
32.21
Total Net profit including share of profit / Loss from associate company
23.68
26.57
14.68
25.74
20.41
25.45
29.3
27.62
24.22
16.09
25.25
32.21
EPS
9.59
10.76
5.95
10.42
8.27
10.31
11.87
11.19
9.81
6.52
10.23
13.05
Actual EPS
9.59
10.76
5.95
10.42
8.27
10.31
11.87
11.19
9.81
6.52
10.23
13.05
Adjusted EPS
9.59
10.76
5.95
10.42
8.27
10.31
11.87
11.19
9.81
6.52
10.23
13.05
Diluted EPS
9.59
10.76
5.95
10.42
8.27
10.31
11.87
11.19
9.81
6.52
10.23
13.05

Novartis India Ltd Annual Profit & Loss

Figures in Rupees Crores

Mar 2018
Mar 2019
Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Mar 2026
Sales
563.88
490.68
438.25
381.35
399.87
378.74
335.07
356.27
354.33
Other Income
171.83
78.26
36.14
33.09
33.19
58.11
61.68
41.96
38.77
Total Income
735.71
568.94
474.39
414.44
433.06
436.85
396.75
398.23
393.1
Expenses
570.13
478.4
426.22
354.56
422.4
313.66
269.81
264.85
260.23
Operating Profit
-6.25
12.28
12.03
26.79
-22.53
65.08
65.26
91.42
94.1
Operating Profit Margin %
-1.11%
2.5%
2.75%
7.03%
-5.63%
17.18%
19.48%
25.66%
26.56%
Profit Before Interest, Tax and Depreciation
165.58
90.54
48.17
59.88
10.66
123.19
126.94
133.38
132.87
Interest
5.53
1.59
6.39
7.68
4.83
1.75
1.49
0.77
1.26
Depreciation
2.53
3.18
13.14
12.16
9.65
6.06
2.61
2.19
1.95
Profit Before Tax
157.52
85.77
28.64
40.04
-3.82
115.38
122.84
130.42
129.66
Tax Paid
79.16
34
18.56
19.14
-0.1
12.02
37.65
29.52
36.48
Profit After Tax
78.36
51.77
10.08
20.9
-3.72
103.36
85.19
100.9
93.18
Total Net profit including share of profit / Loss from associate company
78.36
51.77
10.08
20.9
-3.72
103.36
85.19
100.9
93.18
EPS
28.43
20.97
4.08
8.46
-1.51
41.86
34.5
40.87
37.74
Actual EPS
28.43
20.97
4.08
8.46
-1.51
41.86
34.5
40.87
37.74
Adjusted EPS
28.43
20.97
4.08
8.46
-1.51
41.86
34.5
40.87
37.74
Diluted EPS
28.43
20.97
4.08
8.46
-1.51
41.86
34.5
40.87
37.74

Novartis India Ltd Cash Flow

Figures in Rupees Crores

Mar 2016
Mar 2017
Mar 2018
Mar 2019
Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Mar 2026
Net Cash from Operating Activities
56.59
-40.83
160.99
-194.28
-23.14
-69.21
38.67
44.8
113.4
74.57
46.73
Cash Flow from Investing Activities
-630.47
423.64
68.7
274.23
55.91
95.16
87.04
-153.25
33.13
-3.31
17.63
Cash Flow from Financing Activities
-38.57
-331.8
-267.65
-29.82
-41.41
-36.8
-35.63
-30.48
-120.99
-64.15
-63.93
Net Cash Flow
-612.45
51.01
-37.96
50.13
-8.64
-10.85
90.08
-138.93
25.54
7.11
0.43

Novartis India Stock Shareholding Pattern

Numbers in percentages

Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Jul 2026
Promoters
70.68%
70.68%
70.68%
70.68%
70.68%
70.68%
70.68%
70.68%
70.68%
70.68%
70.68%
70.68%
DII
0.53%
0.53%
0.53%
0.53%
0.53%
0.53%
0.53%
0.53%
0.64%
0.53%
1.36%
1.39%
FII
0.19%
0.19%
0.19%
0.19%
0.19%
0.19%
0.19%
0.19%
0.19%
0.17%
0.16%
0.15%
Public
28.59%
28.6%
28.6%
28.6%
28.6%
28.6%
28.6%
28.6%
28.5%
28.61%
27.8%
27.78%
Total Outstanding Shares
2,46,90,797
2,46,90,797
2,46,90,797
2,46,90,797
2,46,90,797
2,46,90,797
2,46,90,797
2,46,90,797
2,46,90,797
2,46,90,797
2,46,90,797
2,46,90,797
Total Shareholders
43,128
41,239
39,265
39,596
38,926
39,133
39,040
39,353
39,468
38,116
36,502
36,706

Mutual Funds Buying / Exiting Novartis India

Holdings as of 15 Sep 2026 · based on the latest SEBI-mandated portfolio disclosures

Mutual Funds Buying Novartis India

Sorted by largest increase in holding, month-over-month.

Fund Name

Value of Holding

Increase (MoM)

Holding %

Bandhan Healthcare Fund Direct Growth

Bandhan Healthcare Fund Direct Growth

₹6.43 Cr

₹3.15 Cr (+95.97%)

1.54%

HDFC Pharma and Healthcare Fund Direct Growth

HDFC Pharma and Healthcare Fund Direct Growth

₹20.27 Cr

₹0.55 Cr (+2.80%)

0.47%

HDFC MNC Fund Direct Growth

HDFC MNC Fund Direct Growth

₹4.14 Cr

₹0.21 Cr (+5.44%)

0.56%

Mutual Funds Exiting Novartis India

Sorted by largest decrease in holding, month-over-month.

Fund Name

Value of Holding

Decrease (MoM)

Holding %

Bandhan Innovation Fund Direct Growth

Bandhan Innovation Fund Direct Growth

₹4.23 Cr

₹2.01 Cr (-32.20%)

0.12%

Novartis India Corporate Actions

View detailed summary of the earnings and dividend history of Novartis India.

  • Novartis India Ltd Earnings Results

    Novartis India Ltd’s net profit jumped 16.62% since last year same period to ₹32.21Cr in the Q1 2026-2027. On a quarterly growth basis, Novartis India Ltd has generated 27.56% jump in its net profits since last 3-months.

    Read More about Earnings Results

  • Novartis India Ltd Dividends May,2025

    In the quarter ending March 2025, Novartis India Ltd has declared dividend of ₹25.00 per share on 09 May 2025 - translating a dividend yield of 2.09%.

    Read More about Dividends

Indices Featuring Novartis India Stock

Check stock indices that include Novartis India.

BSE Healthcare

₹50,395.68

-83.13 (▲0.16%)

Insights on Novartis India Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 1 month, NOVARTIND stock has moved up by 37.7%

  • imgPOSITIVE IMPACT

    Best in 1 Year

    img

    In the last 1 year, NOVARTIND has outperformed top 5 stocks with highest market-cap in Pharmaceuticals

  • imgPOSITIVE IMPACT

    Best in 3 Years

    img

    In the last 3 years, NOVARTIND has outperformed top 5 stocks with highest market-cap in Pharmaceuticals

  • imgPOSITIVE IMPACT

    MF Holding Up

    img

    Mutual Funds have increased holdings from 0.69% to 0.72% in Jul 2026 quarter

  • imgNO EFFECT

    Promoter Holding Unchanged

    img

    Promoters holdings remained unchanged at 70.68% of holdings in Jul 2026 quarter

  • imgNEGATIVE IMPACT

    Retail Holding Down

    img

    Retail Investor have decreased holdings from 27.80% to 27.78% in Jul 2026 quarter

  • imgNEGATIVE IMPACT

    FII Holding Down

    img

    Foreign Institutions have decreased holdings from 0.16% to 0.15% in Jul 2026 quarter

About Novartis India Ltd

Novartis India Limited (NIL) is a subsidiary of the world's second-largest pharmaceutical company, Swiss giant Novartis. Incorporated in 1947, the company has four core segments- Pharmaceuticals, Generics, Over the Counter, and Animal Health. Its history traces back to the middle of the 18th century when Geigy was founded, followed by Ciba in 1860 and then Sandoz in 1886. It was only in 1996 when the three separate entities merged to become Novartis. In 2000, the company acquired products from SmithKline Beecham and started a Joint Effort to Eradicate Tuberculosis (JEET) in India. The Glivec drug was launched in India in 2002 for which they were awarded TERI's Corporate Social Responsibility award. Over the years the company has alligned with various global organisations inlcuding the WHO to help stem the spread of malaria, as well as launching numerous initiatives including the Arogya Parivar in 2008 to target healthcare needs of villagers. Moreover, between 2000 and 2006, it spent over USD 755 million on research for neglected diseases and patient-access programs.

Revenue: ₹103.81Cr as on June 2026 (Q1 FY27)
Net Profit: ₹32.21Cr as on June 2026 (Q1 FY27)
Listing date: 08 Nov, 1994
Chairperson Name: C Snook
OrganisationNovartis India Ltd
HeadquartersMumbai
IndustryPharmaceuticals
CEOC Snook
E-voting on sharesClick here to vote

FAQs

What is Novartis India share price today?

Novartis India share price today stands at ₹2014 as on . Novartis India share today touched a day high of ₹2178.1 and a low of ₹1980.

What is the 52 week high and 52 week low range for Novartis India share?

Novartis India touched a 52 week high of ₹2588.8 and a 52 week low of ₹950. Novartis India share price today i.e. is trending at ₹2014, which is -22.20% down from its 52 week high and 112.00% up from its 52 week low.

What is Novartis India's market capitalisation today?

Novartis India market capitalisation is ₹5,402.35 Cr as on .

How to buy Novartis India shares?

To buy Novartis India shares, you need to follow these steps:

  • Open a Demat account and Trading account on INDmoney
  • Fund your Trading account
  • Search for NOVARTIND or Novartis India Ltd on the INDmoney app to check live prices of the stock
  • Click on Buy or SIP to place an order to invest in Novartis India shares. You can invest by selecting the number of shares or set up a fixed SIP to invest every month or week.

What is Novartis India trading volume today?

Novartis India trading volume is 1.00L as on . This means that 1.00L shares of Novartis India were bought and sold on the stock market during today's trading session.